Abstract LB053: A novel CD16A-nanobody platform overcomes Fc polymorphism limitations for potent and broad-spectrum NK cell engager therapeutics
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Tiong Sun Chia, Jia Liu, Shuming Lin, Wei Dai, Min Wu, Zhihai Wu
Institution: Innovent Biologics (China)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7154733563
Cites:
Cited by:
Related to: